Artificial intelligence tool to locate presence of 'asbestos cancer' in patients

The Data Lab has today released details of a new project using AI to assess and treat mesothelioma, or'asbestos cancer'. Scottish medical imaging software firm Canon Medical Research Europe and the University of Glasgow are set to publish clinical findings from a study evaluating a new cancer assessment tool, developed as part of the Cancer Innovation Challenge. A study team have created a prototype that can automatically find and measure mesothelioma on CT scans. These scans are then used by the trained AI to assess patient's response to drug treatments like chemotherapy. The AI was trained by showing it over 100 CT scans, on which an expert clinician had drawn around all areas of the tumour – showing the AI what to look for.